Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Clinical trial NCT05416307 · RECRUITING
Trial details
- NCT number
- NCT05416307
- Sponsor
- Electra Therapeutics Inc.
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-19
- Primary completion
- 2027-06-01
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.